Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
6
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition LLC | 10% Owner | 6 | $0 | $0 | 2025-02-18 |
| Stockwell Lynn | CEO and Executive COB | 6 | $0 | $0 | 2025-02-18 |
| Do Catherine | Director | 1 | $0 | $0 | 2025-01-29 |
| Shulgan Myron W. | Director | 1 | $0 | $0 | 2025-01-29 |
| Prasad Sridhar G. | Director | 1 | $0 | $0 | 2025-01-29 |
| Worman Glenn C. | CFO | 1 | $0 | $0 | 2025-01-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Stockwell Lynn | CEO and Exe. Chair of Board | P Buy deriv | 2025-02-18 | 2025-02-18 | 30,000 | — | $0 | 430,000 | SEC↗ |
| Drugs Made In America Acquisit | 10% Owner | P Buy deriv | 2025-02-18 | 2025-02-18 | 30,000 | — | $0 | 430,000 | SEC↗ |
| Stockwell Lynn | CEO and Exe. Chair of Board | P Buy | 2025-02-18 | 2025-02-18 | 30,000 | — | $0 | 4,188,780 | SEC↗ |
| Drugs Made In America Acquisit | 10% Owner | P Buy | 2025-02-18 | 2025-02-18 | 30,000 | — | $0 | 4,188,780 | SEC↗ |
| Stockwell Lynn | CEO and Executive COB | P Buy deriv | 2025-01-29 | 2025-02-04 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Drugs Made In America Acquisit | 10% Owner | P Buy deriv | 2025-01-29 | 2025-02-04 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Worman Glenn C. | CFO | J Other | 2025-01-29 | 2025-02-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Do Catherine | Director | J Other | 2025-01-29 | 2025-02-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Prasad Sridhar G. | Director | J Other | 2025-01-29 | 2025-02-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Shulgan Myron W. | Director | J Other | 2025-01-29 | 2025-02-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Stockwell Lynn | CEO and Executive COB | P Buy | 2025-01-29 | 2025-02-04 | 400,000 | — | $0 | 10,257 | SEC↗ |
| Stockwell Lynn | CEO and Executive COB | J Other | 2025-01-29 | 2025-02-04 | 400,000 | — | $0 | 9,857,143 | SEC↗ |
| Stockwell Lynn | CEO and Executive COB | S Sale | 2025-01-29 | 2025-02-04 | 5,698,363 | — | $0 | 4,158,780 | SEC↗ |
| Drugs Made In America Acquisit | 10% Owner | J Other | 2025-01-29 | 2025-02-04 | 400,000 | — | $0 | 9,857,143 | SEC↗ |
| Drugs Made In America Acquisit | 10% Owner | S Sale | 2025-01-29 | 2025-02-04 | 5,698,363 | — | $0 | 4,158,780 | SEC↗ |
| Drugs Made In America Acquisit | 10% Owner | P Buy | 2025-01-29 | 2025-02-04 | 400,000 | — | $0 | 10,257,143 | SEC↗ |